Evidence map›Paper›PMID 41726482›Full record

ArticleAMIA ... Annual Symposium proceedings. AMIA Symposium2024

Which decisions affect cohort distribution in COVID-19 data analytics?

Atefehsadat Haghighathoseini, Janusz Wojtusiak, Lemba Priscille Ngana, Hua Min, Nirup M Menon

Abstract read
In one paragraph

Article in AMIA ... Annual Symposium proceedings. AMIA Symposium, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Atefehsadat HaghighathoseiniGeorge Mason University, Fairfax, VA, USA.
Janusz WojtusiakGeorge Mason University, Fairfax, VA, USA.
Lemba Priscille NganaGeorge Mason University, Fairfax, VA, USA.
Hua MinGeorge Mason University, Fairfax, VA, USA.
Nirup M MenonGeorge Mason University, Fairfax, VA, USA.

Funding

TASK ORDER NO. 4, STSS PROGRAM SUPPORT AND TRANSITION-IN (4)75N95021D00001 · NIDA · AXLE INFORMATICS, LLC · PI MAYS, GARY · 2021 to 2022
$27.9M
TUBERCULOSIS PREVENTION IN CHILDREN TWO TO LESS THAN 13 YEARS OF AGE WITH AND WITHOUT HIV75N94023D00001 · NICHD · WESTAT, INC. · PI DRIVER, BARBARA · 2023 to 2025
$19.9M
RADX INNOVATION FUNNEL FOR HIV DIAGNOSTICS - AWARD MANAGEMENT75N92023D00001 · NHLBI · VENTUREWELL · 2024 to 2025
$10.0M
Use of Artificial Intelligence/Machine Learning (AI/ML) to Enhance the STEP Pediatric Excipient Database75N93023D00001 · NIAID · ADVANCED BIOSCIENCE LABORATORIES, INC. · PI SILVERA, PETER · 2023 to 2025
$9.6M
CLC NIH HHS 75N90023D00001NICHD NIH HHS 75N94023D00001NIDA NIH HHS 75N93023D00001NIDA NIH HHS 75N95021D00001NIH HHS 75N92023D00001ORFDO NIH HHS 75N99023D00001
6 · The paper itself

Abstract

Data analytics has emerged as a crucial tool for understanding the multifaceted impacts of the COVID-19 pandemic. By collecting and analyzing extensive datasets, researchers have gained valuable insights into the virus's transmission, severity, and the effectiveness of public health measures. Yet, many contradictive and non-reproducible results have been published. The significance of cohort representativeness in this context cannot be overstated, as diverse cohorts provide a comprehensive understanding of how various demographic and clinical factors influence COVID-19 outcomes. This study investigates the impact of decision-making processes on cohort diversity, focusing on demographic categories including sex, race, and ethnicity. Results show that decisions made during data preprocessing and cohort construction increase variability in demographic distribution. Specifically, the difference in female representation varied by 0.77% to 2.68%, in Black race from 1.17% to 5.15%, and in Hispanic or Latino ethnicity from 5.84% to 8.21%. It highlights how arbitrary decisions can lead to varying data including changes to data distribution. Seemingly unrelated to demographics factors, including timing and provider selection, significantly influence patient distribution and outcomes, underscoring the necessity for informed, data-driven strategies. The findings emphasize the importance of strategic, evidence-based decision-making to enhance consistency, optimize resource utilization, and effectively serve diverse populations, ultimately contributing to more equitable health outcomes and informed public health policies.

Indexed as

COVID-19Data AnalyticsDecision MakingEthnicityRace FactorsCohort StudiesFemaleHumansSARS-CoV-2Cohort distributionData ProcessingDecision-makingNational COVID Cohort Collaborative (N3C)

Identifiers

PMID41726482
PMCPMC12919597

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.